Do prescribing formularies help GPs prescribe from a narrower range of drugs? A controlled trial of the introduction of prescribing formularies for NSAIDs

British Journal of General Practice

Volumn 47, Issue 425, 1997, Pages 810-814

  Avery, Anthony J ^a   Walker, Barbara ^b   Heron, Tara ^a   Teasdale, Sheila J ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Lincolnshire MAAG   (United Kingdom)

Author keywords

Controlled trials; Drug formularly; NSAIDs; Prescribing patterns

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG CHOICE; DRUG FORMULARY; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; PRESCRIPTION; UNITED KINGDOM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG UTILIZATION; ENGLAND; FAMILY PRACTICE; FORMULARIES; HUMANS;

EID: 0030699319     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jolloes M. Why not compile your own formulary? J R Coll Gen Pract 1981; 31: 372.
2. Grant GB, Gregory DA, van Zwanenberg TD. Development of a limited formulary for general practice. Lancet 1985; 1: 1030-1032.
3. Reilly P. How to make a formulary work. MIMS magazine, November 1990. pp 33-34.
4. Harris CM, Jarman B, Woodman E, el at. Prescribing - a suitable case for treatment. [Occasional paper 24.] London: Royal College of General Practitioners, 1984.
5. Reilly PM, Horne RA, Gilleghan JD, Eckersley APR. How to produce a practice formulary. London: Royal College of General Practitioners [Clinical Management Folder.] London: RCGP, 1989.
6. Greenfield PR. Report to the Secretary of State for Social Services of the Informal Working Group on Effective Prescribing. London: HMSO. 1982.
7. Department of Health. Improving prescribing: the implementation of the GP indicative prescribing scheme. London: HMSO, 1990.
8. Harding JM, Modell M, Freudenberg S, et al. Prescribing: the power to set limits. BMJ 1985; 290:450-453.
9. McGavock H. Promoting rational therapeutics: the Swedish guidelines and a UK response. Dr J Gen Pract 1990; 40: 1-3.
10. Field J. How do doctors and patients react to the introduction of a practice formulary? Fam Pract 1989; 6: 135-140.
11. Green PE. The general practice formulary - its role in rational therapeutics. J R Coll Gen Pract 1985; 35: 570-572.
12. Hill-Smith I. Sharing resources to create a district drug formulary: a county wide controlled trial. Br J Gen Pract 1996; 46: 271-275.
13. Wyatt TD, Reilly PM, Morrow NC, Passmore CM. Short-lived effects of a formulary on anti-infective prescribing - the need for continuing peer review. Fam Pract 1992; 9: 461-465.
14. Brookes PM, Day RO. Nonsteroidal anti-inflammatory drugs - differences and similarities. N Engl J Med 1991: 324: 1716-1725.
15. Medicines Resource Centre. Choosing a non-steroidal anti-inflammatory drug. MeReC Bulletin 1994; 5: 45-48.
16. Committee on Safety of Medicines and Medicines Control Agency. Relative safety of oral non-aspirin NSAIDs. Current Problems in Pharmacovigilance 1994; 20: 9-11.
17. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical classification index. Oslo: World Health Organization, 1993.
18. Maxwell M, Heaney D, Howie JGR, Noble S. General practice fund-holding: observations on prescribing patterns using the defined daily dose method. BMJ 1993; 307: 1190-1194.
19. Avery AJ, Heron T, Harris, CM, et al. Assessing measures of the range of non-steroidal anti-inflammatory drugs prescribed by general practices as prescribing performance indicators. Br J Med Econ 1996, 10: 69-78
20. McCarthy M., Wilson-Davis K., McGavock H. Relationship between the number of panners in a general practice and the number of different drugs prescribed by that practice. Br J Gen Pract 1992; 42: 10-12.
21. Morton-Jones TJ, Pringle MAL. Prescribing costs in dispensing practices. BMJ 1993; 306: 1244-1246.
22. Harris CM, Fry J, Jarman B, Woodman E. Prescribing - a case for prolonged treatment. J R Coll Gen Pract 1985; 35: 284-287.
23. UK Drug Utilisation Research Group. Report of the sixth national meeting of the UK Drug Utilization Research Group. Pharmacoepidemiology and Drug Safety 1995; 4: 301-304.